FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896522980> ?p ?o ?g. }

• W2896522980 endingPage "804" @default.
• W2896522980 startingPage "796" @default.
• W2896522980 abstract "Objective: In the DUAL (Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes) VII trial, IDegLira (a combination of insulin degludec and liraglutide) was compared with insulin glargine U100 plus insulin aspart. Both treatment approaches achieved similar glycemic control, but there were differences in hypoglycemia, changes in body weight, and injection frequency. The aim of the present analysis was to assess the short-term cost effectiveness of IDegLira versus insulin glargine U100 plus insulin aspart for treatment of patients with type 2 diabetes mellitus not meeting glycemic targets on basal insulin in the U.S. setting. Methods: A cost-utility model was developed to evaluate the clinical and economic outcomes associated with the 2 treatments over a 1-year time horizon, capturing the impact on quality of life of hypoglycemic events, body mass index, and injection frequency. Costs were captured from a healthcare payer perspective in 2017 U.S. dollars ($). Results: IDegLira was associated with improved quality of life by 0.12 quality-adjusted life years compared with insulin glargine U100 plus insulin aspart. The key drivers of this difference were reduced injection frequency and hypoglycemic events avoided. IDegLira was associated with increased annual drug costs, but this was entirely offset by reduced needle costs and reduced costs of self-monitoring of blood glucose testing. IDegLira was associated with total annual cost savings of $743 per patient. Conclusion: IDegLira was found to improve quality-adjusted life expectancy and reduce costs when compared with insulin glargine U100 plus insulin aspart for treatment of patients with type 2 diabetes not achieving glycemic control on basal insulin in the U.S. setting. Abbreviations: ADA = American Diabetes Association; BMI = body mass index; CI = confidence interval; DUAL = Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes; GLP-1 = glucagon-like peptide-1; HbA1c = glycated hemoglobin; ICER = incremental cost-effectiveness ratio; IU = international units; QALY = quality-adjusted life year; SMBG = self-monitoring of blood glucose" @default.
• W2896522980 created "2018-10-26" @default.
• W2896522980 creator A5020446741 @default.
• W2896522980 creator A5034940111 @default.
• W2896522980 creator A5072605000 @default.
• W2896522980 creator A5082192327 @default.
• W2896522980 date "2018-09-01" @default.
• W2896522980 modified "2023-09-27" @default.
• W2896522980 title "Ideglira is Associated With Improved Short-Term Clinical Outcomes and Cost Savings Compared With Insulin Glargine U100 Plus Insulin Aspart in the U.S." @default.
• W2896522980 cites W1526927233 @default.
• W2896522980 cites W1980080164 @default.
• W2896522980 cites W1983269691 @default.
• W2896522980 cites W1992061662 @default.
• W2896522980 cites W2006393945 @default.
• W2896522980 cites W2047094893 @default.
• W2896522980 cites W2067626357 @default.
• W2896522980 cites W2076583826 @default.
• W2896522980 cites W2077725161 @default.
• W2896522980 cites W2089770071 @default.
• W2896522980 cites W2110019707 @default.
• W2896522980 cites W2111824270 @default.
• W2896522980 cites W2118472474 @default.
• W2896522980 cites W2139634859 @default.
• W2896522980 cites W2147222003 @default.
• W2896522980 cites W2158666727 @default.
• W2896522980 cites W2166353747 @default.
• W2896522980 cites W2170271198 @default.
• W2896522980 cites W2170764092 @default.
• W2896522980 cites W2171294019 @default.
• W2896522980 cites W2279577009 @default.
• W2896522980 cites W2314985774 @default.
• W2896522980 cites W2337454357 @default.
• W2896522980 cites W2520696266 @default.
• W2896522980 cites W2537953665 @default.
• W2896522980 cites W2792254305 @default.
• W2896522980 cites W3198570063 @default.
• W2896522980 doi "https://doi.org/10.4158/ep-2018-0134" @default.
• W2896522980 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30308134" @default.
• W2896522980 hasPublicationYear "2018" @default.
• W2896522980 type Work @default.
• W2896522980 sameAs 2896522980 @default.
• W2896522980 citedByCount "5" @default.
• W2896522980 countsByYear W28965229802019 @default.
• W2896522980 countsByYear W28965229802020 @default.
• W2896522980 countsByYear W28965229802022 @default.
• W2896522980 crossrefType "journal-article" @default.
• W2896522980 hasAuthorship W2896522980A5020446741 @default.
• W2896522980 hasAuthorship W2896522980A5034940111 @default.
• W2896522980 hasAuthorship W2896522980A5072605000 @default.
• W2896522980 hasAuthorship W2896522980A5082192327 @default.
• W2896522980 hasBestOaLocation W28965229801 @default.
• W2896522980 hasConcept C126322002 @default.
• W2896522980 hasConcept C134018914 @default.
• W2896522980 hasConcept C2775927303 @default.
• W2896522980 hasConcept C2777180221 @default.
• W2896522980 hasConcept C2779306644 @default.
• W2896522980 hasConcept C2779908123 @default.
• W2896522980 hasConcept C2779920387 @default.
• W2896522980 hasConcept C2780473172 @default.
• W2896522980 hasConcept C2780668416 @default.
• W2896522980 hasConcept C2781308992 @default.
• W2896522980 hasConcept C2910068830 @default.
• W2896522980 hasConcept C555293320 @default.
• W2896522980 hasConcept C71924100 @default.
• W2896522980 hasConceptScore W2896522980C126322002 @default.
• W2896522980 hasConceptScore W2896522980C134018914 @default.
• W2896522980 hasConceptScore W2896522980C2775927303 @default.
• W2896522980 hasConceptScore W2896522980C2777180221 @default.
• W2896522980 hasConceptScore W2896522980C2779306644 @default.
• W2896522980 hasConceptScore W2896522980C2779908123 @default.
• W2896522980 hasConceptScore W2896522980C2779920387 @default.
• W2896522980 hasConceptScore W2896522980C2780473172 @default.
• W2896522980 hasConceptScore W2896522980C2780668416 @default.
• W2896522980 hasConceptScore W2896522980C2781308992 @default.
• W2896522980 hasConceptScore W2896522980C2910068830 @default.
• W2896522980 hasConceptScore W2896522980C555293320 @default.
• W2896522980 hasConceptScore W2896522980C71924100 @default.
• W2896522980 hasIssue "9" @default.
• W2896522980 hasLocation W28965229801 @default.
• W2896522980 hasOpenAccess W2896522980 @default.
• W2896522980 hasPrimaryLocation W28965229801 @default.
• W2896522980 hasRelatedWork W2356750798 @default.
• W2896522980 hasRelatedWork W2809364558 @default.
• W2896522980 hasRelatedWork W2894602661 @default.
• W2896522980 hasRelatedWork W2899009125 @default.
• W2896522980 hasRelatedWork W2999498798 @default.
• W2896522980 hasRelatedWork W3004337187 @default.
• W2896522980 hasRelatedWork W3008112254 @default.
• W2896522980 hasRelatedWork W3048253389 @default.
• W2896522980 hasRelatedWork W4243180672 @default.
• W2896522980 hasRelatedWork W4250981993 @default.
• W2896522980 hasVolume "24" @default.
• W2896522980 isParatext "false" @default.
• W2896522980 isRetracted "false" @default.
• W2896522980 magId "2896522980" @default.
• W2896522980 workType "article" @default.